beur schreef:
Nieuwe SEC filing:
finance.aol.com/company/gtc-biotherap...Hieruit:
"(c) On March 27, 2009, Christian Bechon, the President of LFB and a director of GTC, acquired 15,152 shares of GTC’s Common Stock at his election, pursuant to GTC’s 2002 Equity Incentive Plan, in lieu of the quarterly cash payment of his 2009 director retainer fees. The acquisition was reported in a Form 4 filed with the Commission on March 31, 2009. Other than this acquisition and as set forth in Item 4 above, to the best knowledge of each of LFB and Laboratoire Francais, there have been no transactions in the shares of GTC effected during the past 60 days by LFB or Laboratoire Francais, or by any affiliate, executive officer or director of LFB or Laboratoire Francais."
Voor de mensen die moeite hebben met Engels:
Christian Bechon, de baas van LFB, heeft i.p.v. zijn gebruikelijke kwartaalbeloning 15.152 aandelen GTC ontvangen.
Verder is het nuttig te weten dat LFB de laatste 60 dagen geen effectentransacties met GTC-stukken heeft gedaan.